GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Total Liabilities

Apollomics (Apollomics) Total Liabilities : $14.15 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Total Liabilities?

Apollomics's Total Liabilities for the quarter that ended in Dec. 2023 was $14.15 Mil.

Apollomics's quarterly Total Liabilities declined from Dec. 2022 ($524.60 Mil) to Jun. 2023 ($15.68 Mil) and declined from Jun. 2023 ($15.68 Mil) to Dec. 2023 ($14.15 Mil).

Apollomics's annual Total Liabilities increased from Dec. 2021 ($336.30 Mil) to Dec. 2022 ($524.60 Mil) but then declined from Dec. 2022 ($524.60 Mil) to Dec. 2023 ($14.15 Mil).

Apollomics Total Liabilities Historical Data

The historical data trend for Apollomics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Total Liabilities Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
297.87 336.30 524.60 14.15

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial 336.30 312.00 524.60 15.68 14.15

Apollomics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Apollomics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.556+(0.267+0.33
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14.15

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=55.387-41.234
=14.15

Apollomics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.556+(0.267+0.33
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14.15

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=55.387-41.234
=14.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Apollomics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Total Liabilities
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.